Pharmacologic prevention of restenosis after coronary angioplasty: review of the randomized clinical trials

Coron Artery Dis. 1993 Mar;4(3):232-42. doi: 10.1097/00019501-199303000-00003.
No abstract available

Publication types

  • Review

MeSH terms

  • Angioplasty, Balloon, Coronary*
  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage
  • Anticoagulants / administration & dosage
  • Calcium Channel Blockers / administration & dosage
  • Cardiovascular Agents / administration & dosage*
  • Combined Modality Therapy
  • Coronary Disease / therapy*
  • Fish Oils / administration & dosage
  • Humans
  • Lovastatin / administration & dosage
  • Methylprednisolone / administration & dosage
  • Platelet Aggregation Inhibitors / administration & dosage
  • Randomized Controlled Trials as Topic
  • Recurrence

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Anticoagulants
  • Calcium Channel Blockers
  • Cardiovascular Agents
  • Fish Oils
  • Platelet Aggregation Inhibitors
  • Lovastatin
  • Methylprednisolone